öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÖÜ»ª¸»
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º300

ËùÊôԺУ£º¹ãÎ÷Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ò½Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÍâ¿Æѧ¡¢Íâ¿Æѧ(öλÔÓéÀֵǼÈë¿ÚÏÂÔØÐÍ)
Ñо¿ÁìÓò£º ·Î°©µÄ»ù´¡ÓëÁÙ´²Ñо¿
Ñо¿ÁìÓò£º ·Î°©µÄ»ù´¡ÓëÁÙ´²Ñо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºzhouhuafudr@sina.com


¸öÈ˼òÊö :
ÖÜ»ª¸»£¬1964Äê5Ô³öÉú£¬Ò½Ñ§²©Ê¿£¬¹ãÎ÷Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÐÄÐØÍâ¿Æ½ÌÊÚ¡¢Ö÷ÈÎҽʦ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£ÏÖÈιãÎ÷Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÐÄÐØÍâ¿Æ¸±Ö÷ÈΣ¬¼æÈÎÐØÍâ¿Æ²¡Çø¸±Ö÷ÈΣ¬ÊǹãÎ÷ҽʦЭ»áÐÄÐØÍâ¿Æҽʦ·Ö»á³£ÎñίԱ£¬¹ãÎ÷ҽѧ»áÐØÐÄѪ¹ÜÍâ¿Æ·Ö»áίԱ¡£??????1985Äê±ÏÒµÓÚ¹ãÎ÷ҽѧԺ£¨½ñ¹ãÎ÷Ò½¿Æ´óѧ£©Ò½Ñ§Ïµ£¬1992ÄêÐÄÐØÍâ¿Æѧ˶ʿÑо¿Éú±ÏÒµ£¬2007Äê»ñҽѧ²©Ê¿Ñ§Î»£¬ÔçÄêÔøµ½±±¾©¸·ÍâÐÄѪ¹Ü²¡Ò½Ôº¡¢ÉϺ£¶ùͯҽѧÖÐÐĽøÐÞѧϰ£¬²¢¶à´Îµ½ÃÀ¹ú¡¢¶íÂÞ˹¡¢·¨¹ú¡¢Òâ´óÀûµÈ½øÐÐѧÊõ½»Á÷¡£

¿ÆÑй¤×÷ :
³¤ÆÚ´ÓÊÂÐÄÐØÍâ¿ÆÁÙ´²¡¢½Ìѧ¼°¿ÆÑй¤×÷£¬Ö÷ÒªÑо¿·½ÏòΪÐÄÔàÌø¶¯ÖÐÐÄÄÚÖ±ÊÓÊÖÊõ¼°Ðز¿Ö×ÁöµÄ»ù´¡ÓëÁÙ´²Ñо¿£¬¶Ô·çʪÐÔÐÄÔಡ¡¢ÏÈÌìÐÔÐÄÔಡºÍÐز¿Ö×ÁöµÈ¼²²¡µÄÕïÖÎÓÐϵͳµÄÀíÂÛÑо¿ºÍ·á¸»µÄÁÙ´²¾­Ñ飬ÓÈÆäÔÚÐÄÔà°êĤÖû»Êõ¡¢ÏÈÐIJ¡½ÃÖÎÊõ¡¢·Î°©¸ùÖÎÊõ¡¢Ê³¹Ü°©¸ùÖÎÊõµÈÊÖÊõ·½ÃæÓо«Õ¿µÄ¼¼ÊõºÍ½Ï¸ßµÄÔìÒ裬ÁÙ´²ÖÎÁÆЧ¹ûÊܵ½Í¬Ðм°»¼Õ߹㷺ºÃÆÀ£¬¾­³£µ½¹ãÎ÷¸÷µØÈç¹ó¸Û¡¢ÓñÁÖ¡¢±±º£¡¢ÎàÖÝ¡¢ºØÖݵȵػáÕïÊÖÊõ£¬Äê¾ùÊÖÊõÁ¿½ü500̨¡£
ÏȺó³Ðµ£¶àÏîÊ¡¼¶¿ÆÑÐÏîÄ¿£¬ÆäÖÐ×÷ΪÏîÄ¿¸ºÔðÈËÖ÷³Ö¹ãÎ÷×ÔÈ»¿Æѧ»ù½ð2Ïî¡¢¹ãÎ÷¿Æ¼¼¹¥¹Ø¼Æ»®ÏîÄ¿2Ï½üÄêÀ´ÔÚJ?Recept?Signal?Transduct?Res¡¢J?Renin?Angiotensin?Aldosterone?Syst¡¢Oncol?Lett¡¢Mol?Biol?Rep¡¢PloS?One¡¢Asian?Pac?J?Cancer?Prev¡¢ÖлªÐØÐÄѪ¹ÜÍâ¿ÆÔÓÖ¾¡¢ÖлªÊµÑéÍâ¿ÆÔÓÖ¾¡¢Öйú·Î°©ÔÓÖ¾µÈ¹úÄÚÍâѧÊõ¿¯Îï·¢±íÂÛÎĽü°Ùƪ£¬ÆäÖÐSCIÊÕ¼ÆÚ¿¯12ƪ£¨ÀÛ¼ÆÓ°ÏìÒò×Ó27.33£©£¬×÷ΪÖ÷Òª²ÎÓëÕßÍê³ÉµÄ¡°Ç³µÍÎÂÌåÍâÑ­»·ÐÄÔàÌø¶¯Öжþ¼â°êÖû»ÊõµÄÑо¿¡±ÔøÈÙ»ñ¹ú¼Ò¿Æ¼¼½ø²½ÈýµÈ½±¼°¹ãÎ÷¿Æ¼¼½ø²½Ò»µÈ½±¡£??????½üÄêÀ´ÒÑÅàÑø10¶àÃûÑо¿Éú±ÏÒµ£¬¾ùѧÓÐËù³É£¬·Ö±ðÔÚ±±¾©¡¢ÉϺ£¡¢³É¶¼¡¢ÖØÇìµÈµØ¼°¹ãÎ÷¸÷µØ¹¤×÷¡£½üÄêÀ´³Ðµ£µÄ¿ÆÑÐÏîÄ¿£º¹ãÎ÷¿Æ¼¼¹¥¹Ø¼Æ»®ÏîÄ¿£ºµ°°××éѧɸѡDNA¼×»ù»¯Ïà¹Ø·Î°©±êÖ¾Îï¼°ÔçÆÚÕï¶Ï·½°¸µÄÑо¿£¬¹ð¿Æ¹¥**-1-4£¨ÏîÄ¿¸ºÔðÈË£©¹ãÎ÷×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£ºÐÄ·¿¼¡HCN2»ùÒò¼°IfÓë·çÐĶþÏÁ·¿²ü·¢²¡»úÖƵÄÑо¿£¬2012GXNSFAA053094£¨ÏîÄ¿¸ºÔðÈË£©¹ãÎ÷¿Æ¼¼¹¥¹Ø¼Æ»®ÏîÄ¿£ºÐÄ·¿²ü¶¯ÓëÐÄ·¿¼¡³¬¼«»¯¼¤»î»·ºËÜÕËáÃÅ¿ØͨµÀµ°°×-4±í´ïµÄÑо¿£¬¹ð¿Æ¹¥**-24£¨ÏîÄ¿¸ºÔðÈË£©¹ãÎ÷×ÔÈ»¿Æѧ»ù½ðÏîÄ¿£ºp16¡¢DAP»ùÒò¼×»ù»¯Óë·ÇСϸ°û·Î°©²¡Àí¹ØϵµÄÑо¿£¬¹ð¿Æ×Ô**£¨ÏîÄ¿¸ºÔðÈË£©¹ãÎ÷¿Æ¼¼¹¥¹Ø¼Æ»®ÏîÄ¿£º¹ãÎ÷·Î·ÇСϸ°û°©ÍâÖÜѪÖ×ÁöÏà¹Ø»ùÒò¼×»ù»¯·ÖÎö£¬¹ð¿Æ¹¥**-3-19£¨Ö÷Òª²ÎÓëÕߣ©¹ãÎ÷×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£ºÇ³µÍÎÂÐÄÔ಻ͣÌøÊÖÊõ¹ý³ÌÖÐÄÚ»·¾³µÄ´úл×éѧ¼°µ°°××éѧÑо¿£¬2012GXNSFAA053108£¨Ö÷Òª²ÎÓëÕߣ©½üÄêÀ´²¿·Ö´ú±íÐÔÂÛÖø£º1.Sun?Y,?Liu?W?Z,?Liu?T,?Feng?X,?Yang?N,?Zhou?H?F,Signaling?pathway?of?MAPK/ERK?in?cell?proliferation,?differentiation,?migration,?senescence?and?apoptosis,?J?Recept?Signal?Transduct?Res,?2015,?35(6):?600-604(IF:2.277)£¨Í¨Ñ¶×÷Õߣ©2.Sun?Y,?Liu?W?Z,?Liu?T,?Feng?X,?Yang?N,?Zhou?H?F,Role?of?toll-like?receptors?in?myocardial?infarction,?J?Recept?Signal?Transduct?Res,?2015,?35(5):?420-422(IF:2.277)£¨Í¨Ñ¶×÷Õߣ©3.Liao?S?H,?Liu?W?Z,?Liu?T,?Sun?Y,?Feng?X,?Zhou?H?F,Potential?signaling?pathway?of?hypoxia-inducible?factor?in?lung?cancer?and?its?gene?polymorphism?with?lung?cancer?risk,?J?Recept?Signal?Transduct?Res,?2015,?35(4):?233-237(IF:2.277)£¨Í¨Ñ¶×÷Õߣ©4.Tang?W?Z,?Zhou?H?F,?Li?W,Silver?and?cyanine?staining?of?oligonucleotides?in?polyacrylamide?gel,?PloS?One,?2015,?10(12):?e**(IF:3.234)£¨¹²Í¬µÚÒ»×÷Õߣ©5.Feng?X,?Qin?J?J,?Zheng?B?S,?Huang?L?L,?Xie?X?Y,?Zhou?H?F,Association?of?epidermal?growth?factor?receptor?(EGFR)?gene?polymorphism?with?lung?cancer?risk:?a?systematic?review,?J?Recept?Signal?Transduct?Res,?2014,?34(5):?333-334(IF:1.611)£¨Í¨Ñ¶×÷Õߣ©6.Feng?X,?Zheng?B?S,?Shi?J?J,?Qian?J,?He?W,?Zhou?H?F,A?systematic?review?and?meta-analysis?of?the?association?between?angiotensin?II?type?1?receptor?A1166C?gene?polymorphism?and?myocardial?infarction?susceptibility,?J?Renin?Angiotensin?Aldosterone?Syst,?2014,?15(3):?307-315(IF:2.271)£¨Í¨Ñ¶×÷Õߣ©7.Zhao?Y?X,?Zhou?H?F,?Ma?K?L,?Sun?J?F,?Feng?X,?Geng?J?F,?Gu?J,?Wang?W,Zhang?H?Y,?He?Y?H,?Guo?S?C,?Zhou?X?Y,?Yu?J,?Lin?Q,Abnormal?methylation?of?seven?genes?and?their?associations?with?clinical?characteristics?in?early?stage?non-small?cell?lung?cancer,?Oncol?Lett,?2013,?5(4):?1211-1218(IF:0.987)£¨¹²Í¬µÚÒ»×÷Õߣ©8.Zhou?H?F,?Feng?X,?Zheng?B?S,?Qian?J,?He?W,A?meta-analysis?of?the?relationship?between?glutathione?S-transferase?T1?null/presence?gene?polymorphism?and?the?risk?of?lung?cancer?including?31802?subjects,?Mol?Biol?Rep,?2013,?40(10):?5713-5721(IF:2.506)£¨µÚÒ»×÷Õߣ©9.Feng?X,?Zhou?H?F,?Zheng?B?S,?Shi?J?J,?Luo?C,?Qin?J?J,Association?of?glutathione?S-transferase?P1?gene?polymorphism?with?the?histological?types?of?lung?cancer:?a?meta-analysis,?Mol?Biol?Rep,?2013,?40(3):?2439-2447(IF:2.506)10.Gao?F,?Zhou?H?F,?Li?W,?Zhang?X?R,Detection?of?ligation?products?of?DNA?linkers?with?5'-OH?ends?by?denaturing?PAGE?silver?stain,?PloS?One,?2012,?7(6):?e39251(IF:4.092)£¨¹²Í¬µÚÒ»×÷Õߣ©11.Feng?X,?Zheng?B?S,?Shi?J?J,?Qian?J,?He?W,?Zhou?H?F,Association?of?glutathione?S-transferase?P1?gene?polymorphism?with?the?susceptibility?of?lung?cancer,?Mol?Biol?Rep,?2012,?39(12):?10313-10323(IF:2.929)£¨Í¨Ñ¶×÷Õߣ©12.Feng?X,?Dong?C?Q,?Shi?J?J,?Zhou?H?F,?He?W,?Zheng?B?S,Lack?of?association?of?glutathione?S-transferase?M3?gene?polymorphism?with?the?susceptibility?of?lung?cancer,?Asian?Pac?J?Cancer?Prev,?2012,?13(9):?4465-4468(IF:0.659)13.ÁõÎÄÖÞ£¬ÖÜ»ª¸»£¬ËïÓÍõ¿¡Áú£¬ÕÔ´ºº×£¬·ëÐñ£¬³¬¼¶»¯¼¤»î»·ºËÜÕËáµ÷¿ØͨµÀ»ùÒò¼Ò×å-2ÔÚ·çʪÐÔÐÄÔಡ¶þ¼â°êÏÁÕ­°éÐÄ·¿²ü¶¯»¼ÕßÓÒÐĶú×éÖ¯Öеıí´ï£¬ÖлªÊµÑéÍâ¿ÆÔÓÖ¾£¬2014£¬31£¨3£©£º649-651£¨Í¨Ñ¶×÷Õߣ©14.ËïÓÖÜ»ª¸»£¬ÁõÎÄÖÞ£¬·ëÐñ£¬Ç®¿¡£¬ÕÔ´ºº×£¬·çʪÐÔ°êĤ²¡ÐÄ·¿²ü¶¯»¼ÕßÓÒÐÄ·¿³¬¼«»¯¼¤»îµçÁ÷Ãܶȼ°ÆäͨµÀ±í´ïµÄ±ä»¯£¬ÖлªÊµÑéÍâ¿ÆÔÓÖ¾£¬2013£¬30£¨8£©£º1574-1576£¨Í¨Ñ¶×÷Õߣ©15.·ëÐñ£¬Ö£±¦Ê¯£¬ÖÜ»ª¸»£¬Ê¯¿¡½Ü£¬ñû¼Ò½õ£¬·ÇСϸ°û·Î°©×éÖ¯Öп¹°©1ºÅºÍ×éÖ¯ÒÖÖÆÒò×Ó-1¡¢»ùÖʽðÊôµ°°×ø-9±í´ïÓëÁÙ´²ÉúÎïѧÐÐΪ¹Øϵ£¬ÖлªÊµÑéÍâ¿ÆÔÓÖ¾£¬2013£¬30£¨1£©£º155-15716.Íõ¿¡Áú£¬Ê¯¿¡½Ü£¬ÁõÎÄÖÞ£¬ËïÓÖÜ»ª¸»£¬ÉúÎïÐÅϢѧ·½·¨¶ÔÓ°Ïì·Î°©·¢Éú·¢Õ¹¹Ø¼ü»ùÒòµÄ³õ²½É¸Ñ¡£¬Öйú·Î°©ÔÓÖ¾£¬2012£¬15£¨11£©£º642-645£¨Í¨Ñ¶×÷Õߣ©17.ÙþÀÚ£¬ÖÜ»ª¸»£¬ÕÅÐË»ª£¬Ñ¦°îµÂ£¬·ÇСϸ°û·Î°©ÖÐp16»ùÒò״̬¶ÔhTERT?mRNAµÄÓ°Ï죬ÖлªÐØÐÄѪ¹ÜÍâ¿ÆÔÓÖ¾£¬2010£¬26£¨2£©£º132-133£¨Í¨Ñ¶×÷Õߣ©18.ÙþÀÚ£¬ÖÜ»ª¸»£¬ÕÅÐË»ª£¬Ñ¦°îµÂ£¬¹ù½¨¼«£¬·ëÐñ£¬hTERTmRNAÓëp16µ°°×ÔÚ·ÇСϸ°û·Î°©Öеıí´ï£¬Öйú·Î°©ÔÓÖ¾£¬2009£¬12£¨9£©£º1005-1008£¨Í¨Ñ¶×÷Õߣ©19.ÖÜ»ª¸»£¬ºÎΡ£¬³ÂÃúÎ飬ñû¼Ò½õ£¬·ëÐñ£¬ÁÎÊٺϣ¬¶ùͯÊÒ¼ä¸ôȱËðºÏ²¢¶¯Âöµ¼¹Üδ±ÕµÄÍâ¿ÆÖÎÁÆ£¬ÖлªÐØÐÄѪ¹ÜÍâ¿ÆÔÓÖ¾£¬2004£¬20£¨2£©£º114£¨µÚÒ»×÷Õߣ©